Acknowledgement to Reviewers.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1097, doi. 10.1159/000542092
- Publication type:
- Article
Works matching IS 00302414 AND DT 2024 AND VI 102 AND IP 12
Results: 9
1
2
Changes in Mutations of Cell-Free DNA and Liver Tumor Tissue in Patients with Advanced Hepatocellular Carcinoma before and after Introduction of Lenvatinib.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1072, doi. 10.1159/000540438
- By:
- Publication type:
- Article
3
Artificial Intelligence-Driven Prediction Revealed CFTR Associated with Therapy Outcome of Breast Cancer: A Feasibility Study.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1029, doi. 10.1159/000540395
- By:
- Publication type:
- Article
4
Front & Back Matter.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1, doi. 10.1159/000542950
- Publication type:
- Article
5
Chronic Myeloid Leukemia in Adolescents and Young Adults: Clinicopathological Variables and Outcomes.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1018, doi. 10.1159/000539982
- By:
- Publication type:
- Article
6
Real-World Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Database for Asciminib.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1084, doi. 10.1159/000540542
- By:
- Publication type:
- Article
7
Ubiquitin-Specific Protease 52 as a Prognostic Biomarker Correlates with Tumor Microenvironment and Therapy Response in Colorectal Cancer.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1041, doi. 10.1159/000540441
- By:
- Publication type:
- Article
8
Factors Affecting Recurrence and Survival in Stage IIA Colon Cancer Patients.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1009, doi. 10.1159/000540334
- By:
- Publication type:
- Article
9
Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study.
- Published in:
- Oncology, 2024, v. 102, n. 12, p. 1056, doi. 10.1159/000540055
- By:
- Publication type:
- Article